Europe Peptide Therapeutics Market Size, Share & Industry Trends Analysis Report By Type (Innovative and Generic), By Route of Administration, By Synthesis Technology, By Type of Manufacturers, By Application, By Country and Growth Forecast, 2022 - 2028

The Europe Peptide Therapeutics Market would witness market growth of 5.6% CAGR during the forecast period (2022-2028).

Peptide medications have so many desired qualities, they are transitory in the body due to quick degradation and clearance. Many approaches have been used to boost the stability of peptide therapeutics. Some peptides and proteins have half-lives of only a few minutes, making them inefficient for medication delivery. Peripheral blood-mediated proteolysis, real and hepatic evacuation, and receptor-mediated endocytosis are all mechanisms implicated in their clearance. The molecular weight of the substance is one of the key reasons for its quick clearance.

In Europe, cardiovascular diseases (CVD) continue to be the primary cause of death, accounting for 45% of all deaths in the region, according to the National Library of Medicines. Every year, more than 4 million Europeans die from cardiovascular disease (CVD), mostly coronary heart disease (CHD) and stroke. Many more are admitted to hospitals, and several others acquire long-term disabilities that necessitate lifetime therapies. CVD has huge economic ramifications for Europe, in addition to human misery. CVD is predicted to cost the EU economy €210 billion per year, which includes direct healthcare expenses as well as non-health expenditures such as lost productivity and informal care for people with CVD. The cardiovascular disease mortality rate in Central and Eastern Europe (CEE/CIS) is the highest in the world.

CVD death rates are greater in CEE and CIS, and they occur at younger ages as well. Premature CVD mortality among men in Russia and Belarus (65 years) is more than ten times greater than in Switzerland (300 vs. 26 per 100 000, respectively). Men aged 55–59 years in various CIS nations (Belarus, Kazakhstan, Kyrgyzstan, Russia, and Ukraine) have a higher CVD death rate than men aged 75–79 years in France. When comparing CEE to other European countries, women's premature death patterns are similar to men's, however at lower rates. The requirement for an effective treatment approach for these disorders is at its peak in the region. The adoption of peptide therapeutics is estimated to surge due to this.

The Germany market dominated the Europe Peptide Therapeutics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3,458.3 million by 2028. The UK market is estimated to grow at a CAGR of 4.7% during (2022 - 2028). Additionally, The France market would witness a CAGR of 6.3% during (2022 - 2028).

Based on Type, the market is segmented into Innovative and Generic. Based on Route of Administration, the market is segmented into Parenteral Route, Pulmonary, Mucosal, Oral Route, and Others. Based on Synthesis Technology, the market is segmented into Liquid Phase Peptide Synthesis (LPPS), Solid Phase Peptide Synthesis (SPPS), and Hybrid Technology. Based on Type of Manufacturers, the market is segmented into In-house and Outsourced. Based on Application, the market is segmented into Metabolic, Cardiovascular Disorder, GIT & Renal, Antiinfection & Dermatology, Respiratory, Central Nervous System, Cancer, Pain, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Peptide Therapeutics Market will Hit $58.4 Billion by 2028, at a CAGR of 6.3%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly And Company, AstraZeneca PLC, Teva Pharmaceuticals Industries Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Lonza Group AG, and Amgen, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Innovative
• Generic

By Route of Administration

• Parenteral Route
• Pulmonary
• Mucosal
• Oral Route
• Others

By Synthesis Technology

• Liquid Phase Peptide Synthesis (LPPS)
• Solid Phase Peptide Synthesis (SPPS)
• Hybrid Technology

By Type of Manufacturers

• In-house
• Outsourced

By Application

• Metabolic
• Cardiovascular Disorder
• GIT & Renal
• Antiinfection & Dermatology
• Respiratory
• Central Nervous System
• Cancer
• Pain
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Eli Lilly And Company
• AstraZeneca PLC
• Teva Pharmaceuticals Industries Ltd.
• Novartis AG
• Pfizer, Inc.
• Sanofi S.A.
• GlaxoSmithKline PLC
• Takeda Pharmaceutical Company Limited
• Lonza Group AG
• Amgen, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.1 Objectives
1.2 Market Scope
1.3 Segmentation
1.3.1 Europe Peptide Therapeutics Market, by Type
1.3.2 Europe Peptide Therapeutics Market, by Route of Administration
1.3.3 Europe Peptide Therapeutics Market, by Synthesis Technology
1.3.4 Europe Peptide Therapeutics Market, by Type of Manufacturers
1.3.5 Europe Peptide Therapeutics Market, by Application
1.3.6 Europe Peptide Therapeutics Market, by Country
1.4 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trails
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Europe Peptide Therapeutics Market by Type
4.1 Europe Innovative Market by Country
4.2 Europe Generic Market by Country

Chapter 5. Europe Peptide Therapeutics Market by Route of Administration
5.1 Europe Parenteral Route Market by Country
5.2 Europe Pulmonary Market by Country
5.3 Europe Mucosal Market by Country
5.4 Europe Oral Route Market by Country
5.5 Europe Others Market by Country

Chapter 6. Europe Peptide Therapeutics Market by Synthesis Technology
6.1 Europe Liquid Phase Peptide Synthesis (LPPS) Market by Country
6.2 Europe Solid Phase Peptide Synthesis (SPPS) Market by Country
6.3 Europe Hybrid Technology Market by Country

Chapter 7. Europe Peptide Therapeutics Market by Type of Manufacturers
7.1 Europe In-house Market by Country
7.2 Europe Outsourced Market by Country

Chapter 8. Europe Peptide Therapeutics Market by Application
8.1 Europe Metabolic Market by Country
8.2 Europe Cardiovascular Disorder Market by Country
8.3 Europe GIT & Renal Market by Country
8.4 Europe Antiinfection & Dermatology Market by Country
8.5 Europe Respiratory Market by Country
8.6 Europe Central Nervous System Market by Country
8.7 Europe Cancer Market by Country
8.8 Europe Pain Market by Country
8.9 Europe Others Market by Country

Chapter 9. Europe Peptide Therapeutics Market by Country
9.1 Germany Peptide Therapeutics Market
9.1.1 Germany Peptide Therapeutics Market by Type
9.1.2 Germany Peptide Therapeutics Market by Route of Administration
9.1.3 Germany Peptide Therapeutics Market by Synthesis Technology
9.1.4 Germany Peptide Therapeutics Market by Type of Manufacturers
9.1.5 Germany Peptide Therapeutics Market by Application
9.2 UK Peptide Therapeutics Market
9.2.1 UK Peptide Therapeutics Market by Type
9.2.2 UK Peptide Therapeutics Market by Route of Administration
9.2.3 UK Peptide Therapeutics Market by Synthesis Technology
9.2.4 UK Peptide Therapeutics Market by Type of Manufacturers
9.2.5 UK Peptide Therapeutics Market by Application
9.3 France Peptide Therapeutics Market
9.3.1 France Peptide Therapeutics Market by Type
9.3.2 France Peptide Therapeutics Market by Route of Administration
9.3.3 France Peptide Therapeutics Market by Synthesis Technology
9.3.4 France Peptide Therapeutics Market by Type of Manufacturers
9.3.5 France Peptide Therapeutics Market by Application
9.4 Russia Peptide Therapeutics Market
9.4.1 Russia Peptide Therapeutics Market by Type
9.4.2 Russia Peptide Therapeutics Market by Route of Administration
9.4.3 Russia Peptide Therapeutics Market by Synthesis Technology
9.4.4 Russia Peptide Therapeutics Market by Type of Manufacturers
9.4.5 Russia Peptide Therapeutics Market by Application
9.5 Spain Peptide Therapeutics Market
9.5.1 Spain Peptide Therapeutics Market by Type
9.5.2 Spain Peptide Therapeutics Market by Route of Administration
9.5.3 Spain Peptide Therapeutics Market by Synthesis Technology
9.5.4 Spain Peptide Therapeutics Market by Type of Manufacturers
9.5.5 Spain Peptide Therapeutics Market by Application
9.6 Italy Peptide Therapeutics Market
9.6.1 Italy Peptide Therapeutics Market by Type
9.6.2 Italy Peptide Therapeutics Market by Route of Administration
9.6.3 Italy Peptide Therapeutics Market by Synthesis Technology
9.6.4 Italy Peptide Therapeutics Market by Type of Manufacturers
9.6.5 Italy Peptide Therapeutics Market by Application
9.7 Rest of Europe Peptide Therapeutics Market
9.7.1 Rest of Europe Peptide Therapeutics Market by Type
9.7.2 Rest of Europe Peptide Therapeutics Market by Route of Administration
9.7.3 Rest of Europe Peptide Therapeutics Market by Synthesis Technology
9.7.4 Rest of Europe Peptide Therapeutics Market by Type of Manufacturers
9.7.5 Rest of Europe Peptide Therapeutics Market by Application

Chapter 10. Company Profiles
10.1 Eli Lilly And Company
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.5.2 Acquisition and Mergers:
10.1.5.3 Approvals and Trails:
10.2 AstraZeneca PLC
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.5.2 Acquisition and Mergers:
10.3 Teva Pharmaceutical Industries Ltd.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Product Launches and Product Expansions:
10.3.5.2 Approvals and Acquisitions:
10.4 Novartis AG
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Acquisition and Mergers:
10.4.5.2 Approvals and Trails:
10.5 Pfizer, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional & Segmental Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Acquisition and Mergers:
10.6 Sanofi S.A.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Partnerships, Collaborations, and Agreements:
10.7 GlaxoSmithKline PLC
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expense
10.8 Takeda Pharmaceutical Company Limited
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Regional Analysis
10.8.4 Research & Development Expense
10.8.5 Recent strategies and developments:
10.8.5.1 Partnerships, Collaborations, and Agreements:
10.8.5.2 Approvals and Trails:
10.9 Lonza Group AG
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expenses
10.10. Amgen, Inc.
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expenses
10.10.5 Recent strategies and developments:
10.10.5.1 Partnerships, Collaborations, and Agreements:

TABLE 1 Europe Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 Europe Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Peptide Therapeutics Market
TABLE 4 Acquisition and Mergers– Peptide Therapeutics Market
TABLE 5 Approvals and trails– Peptide Therapeutics Market
TABLE 6 Europe Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 7 Europe Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 8 Europe Innovative Market by Country, 2018 - 2021, USD Million
TABLE 9 Europe Innovative Market by Country, 2022 - 2028, USD Million
TABLE 10 Europe Generic Market by Country, 2018 - 2021, USD Million
TABLE 11 Europe Generic Market by Country, 2022 - 2028, USD Million
TABLE 12 Europe Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 13 Europe Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 14 Europe Parenteral Route Market by Country, 2018 - 2021, USD Million
TABLE 15 Europe Parenteral Route Market by Country, 2022 - 2028, USD Million
TABLE 16 Europe Pulmonary Market by Country, 2018 - 2021, USD Million
TABLE 17 Europe Pulmonary Market by Country, 2022 - 2028, USD Million
TABLE 18 Europe Mucosal Market by Country, 2018 - 2021, USD Million
TABLE 19 Europe Mucosal Market by Country, 2022 - 2028, USD Million
TABLE 20 Europe Oral Route Market by Country, 2018 - 2021, USD Million
TABLE 21 Europe Oral Route Market by Country, 2022 - 2028, USD Million
TABLE 22 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 23 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 24 Europe Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 25 Europe Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 26 Europe Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2018 - 2021, USD Million
TABLE 27 Europe Liquid Phase Peptide Synthesis (LPPS) Market by Country, 2022 - 2028, USD Million
TABLE 28 Europe Solid Phase Peptide Synthesis (SPPS) Market by Country, 2018 - 2021, USD Million
TABLE 29 Europe Solid Phase Peptide Synthesis (SPPS) Market by Country, 2022 - 2028, USD Million
TABLE 30 Europe Hybrid Technology Market by Country, 2018 - 2021, USD Million
TABLE 31 Europe Hybrid Technology Market by Country, 2022 - 2028, USD Million
TABLE 32 Europe Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 33 Europe Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 34 Europe In-house Market by Country, 2018 - 2021, USD Million
TABLE 35 Europe In-house Market by Country, 2022 - 2028, USD Million
TABLE 36 Europe Outsourced Market by Country, 2018 - 2021, USD Million
TABLE 37 Europe Outsourced Market by Country, 2022 - 2028, USD Million
TABLE 38 Europe Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 39 Europe Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 40 Europe Metabolic Market by Country, 2018 - 2021, USD Million
TABLE 41 Europe Metabolic Market by Country, 2022 - 2028, USD Million
TABLE 42 Europe Cardiovascular Disorder Market by Country, 2018 - 2021, USD Million
TABLE 43 Europe Cardiovascular Disorder Market by Country, 2022 - 2028, USD Million
TABLE 44 Europe GIT & Renal Market by Country, 2018 - 2021, USD Million
TABLE 45 Europe GIT & Renal Market by Country, 2022 - 2028, USD Million
TABLE 46 Europe Antiinfection & Dermatology Market by Country, 2018 - 2021, USD Million
TABLE 47 Europe Antiinfection & Dermatology Market by Country, 2022 - 2028, USD Million
TABLE 48 Europe Respiratory Market by Country, 2018 - 2021, USD Million
TABLE 49 Europe Respiratory Market by Country, 2022 - 2028, USD Million
TABLE 50 Europe Central Nervous System Market by Country, 2018 - 2021, USD Million
TABLE 51 Europe Central Nervous System Market by Country, 2022 - 2028, USD Million
TABLE 52 Europe Cancer Market by Country, 2018 - 2021, USD Million
TABLE 53 Europe Cancer Market by Country, 2022 - 2028, USD Million
TABLE 54 Europe Pain Market by Country, 2018 - 2021, USD Million
TABLE 55 Europe Pain Market by Country, 2022 - 2028, USD Million
TABLE 56 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 57 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 58 Europe Peptide Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 59 Europe Peptide Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 60 Germany Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 61 Germany Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 62 Germany Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 63 Germany Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 64 Germany Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 65 Germany Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 66 Germany Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 67 Germany Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 68 Germany Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 69 Germany Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 70 Germany Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 71 Germany Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 72 UK Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 73 UK Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 74 UK Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 75 UK Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 76 UK Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 77 UK Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 78 UK Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 79 UK Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 80 UK Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 81 UK Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 82 UK Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 83 UK Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 84 France Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 85 France Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 86 France Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 87 France Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 88 France Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 89 France Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 90 France Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 91 France Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 92 France Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 93 France Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 94 France Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 95 France Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 96 Russia Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 97 Russia Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 98 Russia Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 99 Russia Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 100 Russia Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 101 Russia Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 102 Russia Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 103 Russia Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 104 Russia Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 105 Russia Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 106 Russia Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 107 Russia Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 108 Spain Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 109 Spain Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 110 Spain Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 111 Spain Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 112 Spain Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 113 Spain Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 114 Spain Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 115 Spain Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 116 Spain Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 117 Spain Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 118 Spain Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 119 Spain Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 120 Italy Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 121 Italy Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 122 Italy Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 123 Italy Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 124 Italy Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 125 Italy Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 126 Italy Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 127 Italy Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 128 Italy Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 129 Italy Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 130 Italy Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 131 Italy Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 132 Rest of Europe Peptide Therapeutics Market, 2018 - 2021, USD Million
TABLE 133 Rest of Europe Peptide Therapeutics Market, 2022 - 2028, USD Million
TABLE 134 Rest of Europe Peptide Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 135 Rest of Europe Peptide Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 136 Rest of Europe Peptide Therapeutics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 137 Rest of Europe Peptide Therapeutics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 138 Rest of Europe Peptide Therapeutics Market by Synthesis Technology, 2018 - 2021, USD Million
TABLE 139 Rest of Europe Peptide Therapeutics Market by Synthesis Technology, 2022 - 2028, USD Million
TABLE 140 Rest of Europe Peptide Therapeutics Market by Type of Manufacturers, 2018 - 2021, USD Million
TABLE 141 Rest of Europe Peptide Therapeutics Market by Type of Manufacturers, 2022 - 2028, USD Million
TABLE 142 Rest of Europe Peptide Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 143 Rest of Europe Peptide Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 144 Key Information – Eli Lilly And Company
TABLE 145 KEY INFORMATION – ASTRAZENECA PLC
TABLE 146 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 147 Key Information – Novartis AG
TABLE 148 Key Information – Pfizer, Inc.
TABLE 149 Key Information – Sanofi S.A.
TABLE 150 Key Information – GlaxoSmithKline PLC
TABLE 151 Key Information – Takeda Pharmaceutical Company Limited
TABLE 152 Key Information – Lonza Group AG
TABLE 153 Key Information – Amgen, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent strategies and developments: Eli Lilly And Company
FIG 5 Recent strategies and developments: AstraZeneca PLC
FIG 6 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
FIG 7 Recent strategies and developments: Novartis AG